
---
title: '国信证券：当前应在医药各细分领域中优选一二线公司中内生成长明确的标的'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=7055'
author: 证券时报网
comments: false
date: Mon, 17 May 2021 15:37:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=7055'
---

<div>   
<p style="text-align: left;">证券时报网讯，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002736" code="002736">国信证券</a>指出，上周生物医药板块整体上涨7.47%，在各行业中处于领涨位置。随着新冠疫苗接种有序推进，疫苗板块从专利豁免的情绪冲击中恢复，带领生物制品板块上涨10.26%，领涨各生物医药子版块；中药、骨科等板块在政策刺激下也迎来了反弹。我们认为，当前时点应在各细分领域中优选一二线公司中内生成长明确的标的，尤其是在后疫情时代全球竞争优势更加凸显的个股，以及部分细分产业链中出现结构性改善机会的标的；关注：<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600196" code="600196">复星医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600276" code="600276">恒瑞医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300760" code="300760">迈瑞医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600079" code="600079">人福医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300003" code="300003">乐普医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000739" code="000739">普洛药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002603" code="002603">以岭药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300244" code="300244">迪安诊断</a>；港股威高股份、金斯瑞生物科技、远大医药、锦欣生殖。</p>
                  
</div>
            